Giant Biogene Holding Co (HKSE:02367) EV-to-Revenue : 12.32 (As of May. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Giant Biogene Holding Co's enterprise value is HK$47,500 Mil. Giant Biogene Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,855 Mil. Therefore, Giant Biogene Holding Co's EV-to-Revenue for today is 12.32.

The historical rank and industry rank for Giant Biogene Holding Co's EV-to-Revenue or its related term are showing as below:

HKSE:02367' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.9 Med: 12.49 Max: 21.56
Current: 12.32

During the past 5 years, the highest EV-to-Revenue of Giant Biogene Holding Co was 21.56. The lowest was 6.90. And the median was 12.49.

HKSE:02367's EV-to-Revenue is ranked worse than
94.71% of 1873 companies
in the Consumer Packaged Goods industry
Industry Median: 1.17 vs HKSE:02367: 12.32

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Giant Biogene Holding Co's stock price is HK$52.55. Giant Biogene Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.93. Therefore, Giant Biogene Holding Co's PS Ratio for today is 13.36.

Giant Biogene Holding Co EV-to-Revenue Historical Data

The historical data trend for Giant Biogene Holding Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co EV-to-Revenue Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

11.74

8.00

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial			-	-	11.74	-	8.00

Competitive Comparison of Giant Biogene Holding Co's EV-to-Revenue

For the Household & Personal Products subindustry, Giant Biogene Holding Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's EV-to-Revenue falls into.

Giant Biogene Holding Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Giant Biogene Holding Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	47500.260	/	3854.636
	=	12.32

Giant Biogene Holding Co's current Enterprise Value is HK$47,500 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,855 Mil.

Giant Biogene Holding Co (HKSE:02367) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Giant Biogene Holding Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	52.55	/	3.932
	=	13.36

Giant Biogene Holding Co's share price for today is HK$52.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.93.

Giant Biogene Holding Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines